作为可开发的mPGES-1抑制剂,具有甲胺末端封闭子结构的2 - 烯基索醇
Tansu Yalçın1, Paul M Jordan2,3, Abdurrahman Olğaç1
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
新型的2 - 乙提亚衍生物抑制人类微小体质前列腺素E2 (PGE2) 合成酶-1 (mPGES-1). 化合物21显示强大的PGE2抑制和选择性,为抗炎药物开发提供了一个新的支架.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 微体质前列腺素E2 (PGE2) 合成酶-1 (mPGES-1) 是抗炎药物的关键标.
- 抑制mPGES-1为炎症条件提供了一个治疗策略.
研究的目的:
- 设计和合成新型的2-phenylbenzothiazole衍生物作为mPGES-1抑制剂.
- 评估这些化合物对mPGES-1的抑制潜力和选择性.
主要方法:
- 合成2 - 二二醇衍生物与二二胺的末端封装.
- 无细胞检测测量PGE2形成并确定IC50值.
- 对循环氧化酶 (COX) -1,COX-2,5-脂氧化酶 (5-LOX) 和FLAP进行选择性分析.
主要成果:
- 几种新型衍生物显示出人类mPGES-1的强烈抑制,IC50值在0.72-3.40μM之间.
- 化合物21中含有诺二的一小部分,表现出最强的抑制 (IC50 = 0.72μM).
- 化合物21对相关的炎症酶如COX-1,COX-2,5-LOX和FLAP具有很高的选择性.
结论:
- 开发的2 - 乙提亚衍生物是人类mPGES-1的有效抑制剂.
- 化合物21是开发更安全,更有效的抗炎药物的有希望的化合物.
- 这项研究为未来的炎症药物发现提供了一个新的化学支架.
更多相关视频
10:42Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
Published on: January 3, 2018
11:04Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
相关概念视频
Preparation and Reactions of Sulfides
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
Nomenclature of Aryl and Heterocyclic Amines
Criteria for Aromaticity and the Hückel 4n + 2 Rule
For the first time, Eric Hückel, a German chemical physicist, derived a set of structural features for a compound to be classified as aromatic. This is now known as...
Nomenclature of Aromatic Compounds with a Single Substituent
Electrophilic Aromatic Substitution: Sulfonation of Benzene
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)